Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 10 de 10
Filtrar
2.
Clin Chem ; 57(11): 1566-73, 2011 Nov.
Artigo em Inglês | MEDLINE | ID: mdl-21920914

RESUMO

BACKGROUND: Although measurement of whole-blood creatinine at the point of care offers rapid assessment of renal function, agreement of point-of-care (POC) results with central laboratory methods continues to be a concern. We assessed the influence of several potential interferents on POC whole-blood creatinine measurements. METHODS: We compared POC creatinine (Nova StatSensor) measurements with plasma enzymatic (Roche Modular) and isotope dilution mass spectrometry (IDMS) assays in 119 hospital inpatients. We assessed assay interference by hematocrit, pH, pO(2), total and direct bilirubin, creatine, prescribed drugs, diagnosis, red blood cell water fraction, and plasma water fraction. RESULTS: CVs for POC creatinine were 1.5- to 6-fold greater than those for plasma methods, in part due to meter-to-meter variation. Regressioncomparison of POC creatinine to IDMS results gave a standard error (S(y|x)) of 0.61 mg/dL (54 µmol/L), whereas regression of plasma enzymatic creatinine to IDMS was S(y|x) 0.16 mg/dL (14 µmol/L). By univariate analysis, bilirubin, creatine, drugs, pO(2), pH,plasma water fraction, and hematocrit were not found to contribute to method differences. However, multivariate analysis revealed that IDMS creatinine, red blood cell and plasma water fractions, and hematocrit explained 91.8% of variance in POC creatinine results. CONCLUSIONS: These data suggest that whole-blood POC creatinine measurements should be used with caution. Negative interferences observed with these measurements could erroneously suggest adequate renal function near the decision threshold, particularly if estimated glomerular filtration rate is determined. Disparity between whole-blood and plasma matrices partially explains the discordance between whole-blood and plasma creatinine methods.


Assuntos
Creatinina/sangue , Sistemas Automatizados de Assistência Junto ao Leito , Enzimas , Reações Falso-Negativas , Feminino , Taxa de Filtração Glomerular , Humanos , Técnicas de Diluição do Indicador , Indicadores e Reagentes , Pacientes Internados , Unidades de Terapia Intensiva , Nefropatias/sangue , Nefropatias/diagnóstico , Modelos Lineares , Masculino , Espectrometria de Massas , Pessoa de Meia-Idade , Análise Multivariada , Serviço Hospitalar de Oncologia , Sistemas Automatizados de Assistência Junto ao Leito/normas , Padrões de Referência
3.
Clin Biochem ; 70: 30-33, 2019 Aug.
Artigo em Inglês | MEDLINE | ID: mdl-31170380

RESUMO

OBJECTIVE: To develop a tool to assess the clinical accuracy of glucose meter performance using an insulin dosing protocol to assess the frequency and extent of error in insulin dose categories. METHODS: Retrospective comparison of 1815 glucose meter and central laboratory glucose results obtained from 1698 critically ill patients was conducted using the Parkes error grid, Surveillance error grid and an insulin dose error assessment grid with a sliding scale insulin dosing protocol used to manage critically ill patients. RESULTS: Parkes error grid and Surveillance error grid analyses indicated little risk conferred with the glucose meter results. Insulin dose error assessment grid complemented the aforementioned consensus error grids by determining quantifiable metrics, insulin dose category errors. Insulin dose error analysis indicated that 76.8% (1395/1815) would not have any change in insulin dose, 99.2% (1800/1815) within ±1 insulin dose category, 99.9% (1814/1815) within ±2 categories and 100% within ±3 insulin dose categories. CONCLUSIONS: Analysis with an insulin dose error grid provides information about the frequency and extent of insulin dose category errors with a specific insulin dosing protocol and describes potential clinical impact of glucose meter error.


Assuntos
Automonitorização da Glicemia/instrumentação , Glicemia/metabolismo , Insulina/administração & dosagem , Erros de Medicação , Feminino , Humanos , Masculino , Pessoa de Meia-Idade , Estudos Retrospectivos
4.
Diabetes Technol Ther ; 10(2): 111-20, 2008 Apr.
Artigo em Inglês | MEDLINE | ID: mdl-18260774

RESUMO

BACKGROUND: Most glucose meter comparisons to date have focused on performance specifications likely to impact subcutaneous dosing of insulin. We evaluated four hospital-based glucose meter technologies for accuracy, precision, and analytical interferences likely to be encountered in critically ill patients, with the goal of identifying and discriminating glucose meter performance specifications likely to impact intensive intravenous insulin dosing. METHODS: Precision, both within-run and day-to-day, was evaluated on all four glucose meters. Accuracy (bias) of the meters and analytical interference were evaluated by comparing results obtained on whole blood specimens to plasma samples obtained from these whole blood specimens run on a hexokinase reference method. RESULTS: Precision was acceptable and differed little between meters. There were significant differences in the degree to which the meters correlated with the reference hexokinase method. Ascorbic acid showed significant interference with three of the four meters. Hematocrit also affected the correlation between whole blood and plasma hexokinase glucose on three of the four glucose meters tested, with the magnitude of this interference also varying by glucose meter technology. CONCLUSIONS: Correlation to plasma hexokinase values and hematocrit interference are the main variables that differentiate glucose meters. Meters that correlate with plasma glucose measured by a reference method over a wide range of glucose concentrations and minimize the effects of hematocrit will allow better glycemic control for critically ill patients.


Assuntos
Análise Química do Sangue/instrumentação , Glicemia/efeitos dos fármacos , Glicemia/metabolismo , Hematócrito , Unidades de Terapia Intensiva , Acetaminofen/farmacologia , Anti-Inflamatórios não Esteroides/farmacologia , Ácido Ascórbico/farmacologia , Análise Química do Sangue/normas , Estado Terminal , Relação Dose-Resposta a Droga , Hexoquinase/sangue , Humanos , Insulina/uso terapêutico , Lactatos/farmacologia , Maltose/farmacologia , Reprodutibilidade dos Testes
6.
J Diabetes Sci Technol ; 5(6): 1449-52, 2011 Nov 01.
Artigo em Inglês | MEDLINE | ID: mdl-22226263

RESUMO

BACKGROUND: Off-meter dosed photometric glucose-oxidase-based glucose meters have been reported to be susceptible to interference by hydrogen-peroxide-based disinfecting agents. The objective of this study was to determine if a single application of hydrogen-peroxide-containing Accel® wipe to disinfect an on-meter dosed amperometric glucose-oxidase-based glucose meter will influence its performance. METHOD: The performance of five on-meter dosed amperometric glucose-oxidase-based glucose meters was determined before and after disinfecting the devices with a single application of either CaviWipes® (14.3% isopropanol and 0.23% diisobutyl-phenoxy-ethoxyethyl dimethyl benzyl ammonium chloride) or Accel (0.5% hydrogen peroxide) wipes. Replicate glucose measurements were conducted before disinfecting the devices, immediately after disinfecting, and then 1 and 2 min postdisinfecting, with measurements in triplicate. Analysis was sequentially completed for five different meters. Results were analyzed by a two-way analysis of variance (Analyze-it software). RESULTS: No clinical (<0.3 mmol/liter) or statistical differences (p > .05) in glucose concentration were detected when the on-meter dosed amperometric glucose-oxidase-based glucose meters were disinfected with either CaviWipes or Accel wipes and measured immediately or 1 or 2 min postdisinfecting. No clinically significant difference in glucose concentration was detected between meters (<0.3 mmol/liter). CONCLUSION: The on-meter dosed glucose oxidase amperometric-based glucose meters are not analytically susceptible to interference by a single application of hydrogen-peroxide-containing Accel disinfectant wipes.


Assuntos
Glicemia/análise , Desinfetantes , Desinfecção/métodos , Oxirredutases/metabolismo , Análise Química do Sangue/métodos , Humanos , Peróxido de Hidrogênio/metabolismo
7.
J Diabetes Sci Technol ; 4(6): 1479-94, 2010 Nov 01.
Artigo em Inglês | MEDLINE | ID: mdl-21129345

RESUMO

BACKGROUND: Patients and physicians expect accurate whole blood glucose monitoring even when patients are anemic, are undergoing peritoneal dialysis, or have slightly elevated ascorbate levels. The objective of this study was to estimate analytical error in two consumer and two hospital glucose meters contributed by variations in hematocrit, maltose, ascorbate, and imprecision. METHODS: The influence of hematocrit (20-60%), maltose, and ascorbate were tested alone and in combination with each glucose meter and with a reference plasma glucose method at three concentrations of glucose. Precision was determined by consecutive analysis (n=20) at three levels of glucose. Multivariate regression analysis was used to estimate the bias associated with the interferences, alone and in combination. Total analytical error was estimated as |% bias|+1.96 (% imprecision). RESULTS: Three meters demonstrated hematocrit bias that was dependent upon glucose concentration. Maltose had profound concentration-dependent positive bias on the consumer meters, and the extent of maltose bias was dependent on hematocrit. Ascorbate produced small but statistically significant biases on three meters. Coincident low hematocrit, presence of maltose, and presence of ascorbate increased the observed bias and was summarized by estimation of total analytical error. Among the four glucose meter devices assessed, estimates of total analytical error in glucose measurement ranged from 6 to 68% under the conditions tested. CONCLUSIONS: The susceptibility of glucose meters to clinically significant analytical biases is highly device-dependent, and low hematocrit exacerbated the observed analytical error.


Assuntos
Ácido Ascórbico/sangue , Automonitorização da Glicemia/instrumentação , Glicemia/análise , Hematócrito , Hospitais , Maltose/sangue , Sistemas Automatizados de Assistência Junto ao Leito , Fitas Reagentes , Adulto , Viés , Biomarcadores/sangue , Automonitorização da Glicemia/normas , Desenho de Equipamento , Humanos , Modelos Lineares , Análise Multivariada , Sistemas Automatizados de Assistência Junto ao Leito/normas , Valor Preditivo dos Testes , Fitas Reagentes/normas , Valores de Referência , Reprodutibilidade dos Testes
8.
Clin Biochem ; 43(1-2): 186-92, 2010 Jan.
Artigo em Inglês | MEDLINE | ID: mdl-19769953

RESUMO

OBJECTIVES: Glucose meters are widely used in self and hospital monitoring of blood glucose. We examined the analytical performance of a StatStrip glucose monitoring system. DESIGN AND METHODS: Linearity, % recovery and within-run imprecision were studied using glucose-spiked whole blood. A total of 120 heparinized samples were used in method comparison using a plasma hexokinase on the Dimension RxL MAX analyzer as the comparison method. Common interferences were tested on the StatStrip, Accu-Chek Advantage and the MediSense Optium glucose meters at low, middle and high glucose levels. RESULTS: The StatStrip assay showed excellent linearity and recovery. The coefficient of variations for imprecision were <5%. This meter correlated well with the comparison method (y=0.994X+0.03; r=0.995, S(y/x)=0.05 mmol/L, bias=-0.01 mmol/L). Of the three meters tested, only the StatStrip showed interference <10% for all spiked levels of acetaminophen, ascorbic acid, maltose and hematocrit at three levels of glucose tested. CONCLUSIONS: The StatStrip meter showed good performance and is suitable for point-of-care hospital glucose testing.


Assuntos
Análise Química do Sangue/instrumentação , Análise Química do Sangue/normas , Automonitorização da Glicemia/instrumentação , Automonitorização da Glicemia/normas , Glicemia/análise , Acetaminofen/análise , Ácido Ascórbico/análise , Técnicas Biossensoriais/instrumentação , Técnicas Biossensoriais/métodos , Análise Química do Sangue/métodos , Automonitorização da Glicemia/métodos , Humanos , Maltose/análise , Sistemas Automatizados de Assistência Junto ao Leito , Fitas Reagentes , Valores de Referência , Reprodutibilidade dos Testes , Sensibilidade e Especificidade
9.
Clin Biochem ; 43(10-11): 905-9, 2010 Jul.
Artigo em Inglês | MEDLINE | ID: mdl-20346933

RESUMO

OBJECTIVES: To develop and apply a mathematical model of the relationship between hematocrit, meter glucose and reference glucose concentrations as a tool for evaluation of whole blood glucose meters. DESIGN AND METHODS: Patient blood gas specimens were used to compare the LifeScan SureStep Flexx and the Nova StatStrip glucose meters with reference results obtained from a Radiometer 725 blood gas analyzer. Linear regression analysis was conducted to determine the extent that patient hematocrit and reference glucose concentrations predicted the performance of the glucose meters. RESULTS: Bland-Altman graphic analysis depicted that both glucose meters showed variance with the reference method. A mathematical model was derived from IFCC consensus equations that relate glucose meter results, hematocrit and plasma glucose values. Using the model, multivariate regression depicted that hematocrit affected the results of the SureStep Flexx meter in a manner dependent on the glucose concentration, whereas the StatStrip meter was not affected by hematocrit. CONCLUSIONS: Linear regression can be used to quantify the extent of hematocrit interference on the performance of glucose meters.


Assuntos
Análise Química do Sangue/instrumentação , Glicemia/análise , Hematócrito/instrumentação , Modelos Lineares , Análise Química do Sangue/métodos , Hematócrito/métodos , Humanos , Valor Preditivo dos Testes , Sensibilidade e Especificidade
10.
J Autom Methods Manag Chem ; 2005: 8-25, 2005.
Artigo em Inglês | MEDLINE | ID: mdl-18924721

RESUMO

MODULAR ANALYTICS (Roche Diagnostics) (MODULAR ANALYTICS, Elecsys and Cobas Integra are trademarks of a member of the Roche Group) represents a new approach to automation for the clinical chemistry laboratory. It consists of a control unit, a core unit with a bidirectional multitrack rack transportation system, and three distinct kinds of analytical modules: an ISE module, a P800 module (44 photometric tests, throughput of up to 800 tests/h), and a D2400 module (16 photometric tests, throughput up to 2400 tests/h). MODULAR ANALYTICS allows customised configurations for various laboratory workloads. The performance and practicability of MODULAR ANALYTICS were evaluated in an international multicentre study at 16 sites. Studies included precision, accuracy, analytical range, carry-over, and workflow assessment. More than 700 000 results were obtained during the course of the study. Median between-day CVs were typically less than 3% for clinical chemistries and less than 6% for homogeneous immunoassays. Median recoveries for nearly all standardised reference materials were within 5% of assigned values. Method comparisons versus current existing routine instrumentation were clinically acceptable in all cases. During the workflow studies, the work from three to four single workstations was transferred to MODULAR ANALYTICS, which offered over 100 possible methods, with reduction in sample splitting, handling errors, and turnaround time. Typical sample processing time on MODULAR ANALYTICS was less than 30 minutes, an improvement from the current laboratory systems. By combining multiple analytic units in flexible ways, MODULAR ANALYTICS met diverse laboratory needs and offered improvement in workflow over current laboratory situations. It increased overall efficiency while maintaining (or improving) quality.

SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA